NPDR
Showing 26 - 50 of 90
Diabetic Retinopathy Trial in Guadalajara (Combined antioxidant therapy, Placebo)
Completed
- Diabetic Retinopathy
- Combined antioxidant therapy
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics,
Mar 21, 2022
Specular Microscopy in Proliferative Diabetic Retinopathy
Not yet recruiting
- Corneal Endothelial Cell Changes in Diabetic Patients
- Specular microscopy
- (no location specified)
Apr 28, 2023
WF and PR OCTA in Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
-
Portland, OregonOregon Health & Science University
Sep 21, 2021
Liver X Receptor asNovel Therapeutic Target in Diabetic
Recruiting
- Diabetic Retinopathy
- blood draw
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 13, 2021
Diabetic Retinopathy Trial in Créteil (Nutrof, Meralut)
Recruiting
- Diabetic Retinopathy
- Nutrof
- Meralut
-
Créteil, Creteil, FranceCHI Creteil
Dec 14, 2022
OCT Biomarkers for Diabetic Retinopathy
Active, not recruiting
- Diabetic Retinopathy
-
Portland, OregonOregon Health & Science University
Jul 13, 2021
Diabetic Retinopathy Trial in Beijing (RC28-E injection)
Recruiting
- Diabetic Retinopathy
- RC28-E injection
-
Beijing, Beijing, ChinaBeijing Hospital
Jun 10, 2021
Nonproliferative Diabetic Retinopathy Trial in Worldwide (Intravitreal aflibercept injection [IAI], Sham)
Completed
- Nonproliferative Diabetic Retinopathy
- Intravitreal aflibercept injection [IAI]
- Sham
-
Phoenix, Arizona
- +88 more
Jul 15, 2020
Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Riyadh (Bevacizumab)
Completed
- Non-proliferative Diabetic Retinopathy
- +2 more
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Dec 2, 2021
Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)
Recruiting
- Diabetic Retinopathy
- Runcaciguat (BAY1101042)
- Placebo
-
Redlands, California
- +85 more
Jan 30, 2023
Diabetic Macular Edema Trial in France (Dexamethasone with 2 loading doses followed by PRN regimen.)
Recruiting
- Diabetic Macular Edema
- Dexamethasone with 2 loading doses followed by PRN regimen.
-
Avignon, France
- +19 more
Feb 25, 2022
Diabetic Macular Edema - Obstructive Sleep Apnea Relationship
Active, not recruiting
- Diabetic Macular Edema
- +2 more
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Brampton, Otario, CanadaUptown Eye Speicialists
Nov 23, 2020
Nonproliferative Diabetic Retinopathy Trial (Lucentis)
Completed
- Nonproliferative Diabetic Retinopathy
- (no location specified)
May 8, 2020
Diabetic Retinopathy Trial in Houston, The Woodlands (Aflibercept Injection)
Completed
- Diabetic Retinopathy
- Aflibercept Injection
-
Houston, Texas
- +1 more
May 19, 2021
Diabetic Retinopathy, Artificial Intelligence, Screening Trial in Bangkok (Artificial Intelligence)
Not yet recruiting
- Diabetic Retinopathy
- +2 more
- Artificial Intelligence
-
Bangkok, ThailandRajavithi hospital
Dec 22, 2021
Mild Non-proliferative Diabetic Retinopathy, Cataract Diabetic, Diabetic Retinopathy Trial in Shanghai (Ranibizumab Injection
Recruiting
- Mild Non-proliferative Diabetic Retinopathy
- +2 more
- Ranibizumab Injection [Lucentis]
- Phacoemulsification
-
Shanghai, Shanghai, ChinaDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical,
May 18, 2022
Nonproliferative Diabetic Retinopathy Trial in United States (AKB-9778, Placebo)
Completed
- Nonproliferative Diabetic Retinopathy
- AKB-9778
- Placebo
-
Phoenix, Arizona
- +52 more
Jul 24, 2019
Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy Trial in Torrance
Completed
- Diabetic Macular Edema
- +2 more
- dexamethasone intravitreal implant
- intravitreal bevacizumab
-
Torrance, CaliforniaRetina Macula Institute
Mar 8, 2021
Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)
Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)
Diabetes, Diabetic Nephropathies Trial in Singapore (Fenofibrate)
Recruiting
- Diabetes Mellitus
- Diabetic Nephropathies
-
Singapore, SingaporeSingapore General Hospital
Dec 10, 2020
Severe Non-proliferative Diabetic Retinopathy Trial in Manchester (Green Pascal, Yellow Pascal)
Withdrawn
- Severe Non-proliferative Diabetic Retinopathy
- Green Pascal
- Yellow Pascal
-
Manchester, England, United KingdomCentral Manchester Foundation Trust
Mar 16, 2020